Pumpinheart

Advanced HF and Transplant Cardiologist Dr. Aditi Nayak joins the Pumpinheart clinical advisory board. Dr. Aditi Nayak is an advanced heart failure and transplant cardiologist at BSW Health (Baylor Scott & White) Dallas, TX, and a Clinical Assistant Professor at Texas A&M University School of Medicine. She completed her fellowship in advanced heart failure and transplant cardiology at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, and holds a Master’s degree in Biomedical Innovation and Development from Georgia Institute of Technology’s Department of Bioengineering. Dr. Nayak’s primary research foci are: 1. Elucidating biological and social determinants of sex and race disparities in the pathophysiology and management of heart failure; 2. The application of medical device innovation, particularly in the realm of mechanical circulatory support, to address these disparities. She is the recipient of several research awards for her work in these areas, including the prestigious Philip K Caves Award awarded by the ISHLT - International Society for Heart and Lung Transplantation in 2022. She has also served as elected chair of the 2023 Gordon Research Seminar for Assisted Circulation. Dr. Nayak looks forward to bringing her expertise in women’s health in the context of heart failure, and mechanical circulatory support, to the Pumpinheart team. #heartfailure #ISHLT2024 #clinicalresearch #mcs #LVAD #interventionalcardiology #clinicalspecialist

Pumpinheart teams up with CADFEM (UK-IE) At Pumpinheart, collaborating with partners who appreciate the unique needs of the startup community is essential to our mission. CADFEM (UK-IE) has been an invaluable ally on our journey towards developing our innovative medical solutions. Their commitment to offering comprehensive support for startups has been second to none. With CADFEM (UK-IE)'s one-stop-shop bundle, we've seamlessly accessed high-end simulations without sacrificing our focus on core technology.   What sets CADFEM (UK-IE) 's service apart is their genuine understanding and dedication to tailoring services to meet our specific needs and budget. Their expertise in simulation spans the entire product lifecycle, perfectly aligning with our goal of delivering safe and effective devices to the market while navigating regulatory processes efficiently. Their support has been invaluable. I highly recommend them to fellow startups and encourage them to contact Linda Sweeney sooner rather than later.   #Pumpinheart #Startups #Simulation #MedicalDevice #MedTech #Biotech #CADFEM

Many thanks to the many LVAD and pVAD manufacturers and interventional cardiologists attending the Innovator Day poster presentation and that showed such interest in Pumpinheart's device to treat advanced stage HFpEF, a massive unmet medical need!

Pumpinheart welcomes engineer/scientist Ertan Taskin PhD MS to its biomedical engineering advisory board where he joins his ex-HeartWare Inc pioneering heart pump engineering colleagues John Rudser and Charles Shambaugh. Pumpinheart look forward to Ertan's guidance on the hydraulics aspects of the blood pump design and optimisation of Pumpinheart's implantable diastolic ventricular assist device (VAD) to treat Heart Failure with preserved Ejection Fraction (HFpEF). #HeartFailure #meddevice #medtechinnovator #SparkCrowdfunding

Should you be interested in investing in Pumpinheart then why not take this opportunity for an Irish lunchtime Spark Crowdfunding webinar (1pm IST on Tues 21st May 2024) to meet Pumpinheart's founding team - Darragh Colgan (CTO), Aamir Hameed (CMO & PI), Donald Hickey (CEO) and Andrew Malone (CSO) - and; the German MedTech consultant and MedTech business angel investor - Steffen Ruschinski - that made the first significant private investment in Pumpinheart? All at Pumpinheart are keen to meet you.  #SparkCrowdfunding  #medtech  #medicaldevices  #mti https://lnkd.in/eVkauCkZ

Pumpinheart's e-Poster session presented by Darragh Colgan at euroPCR Paris 2024 interventional cardiology conference Innovators' Day (13th May) attracted a lot of interest and a description is included in the euroPCR Innovation Book, "a handy resource designed to keep you up to date with the future of cardiovascular care". Poster session attendees we able to get their hands on some of Pumpinheart's earliest prototypes of the device and its anchoring system. https://lnkd.in/gxdC9CSH #Sparkcrowdfunding

Join Pumpinheart CTO Darragh Colgan presenting E-poster "Miniature implantable pump to treat diastolic heart failure" on PCR Innovator's Day 13th May at euro PCR 2024, Paris, and throughout the conference! #EuroPCR #paris #medtech #medicaldevices #lifesciences #sparkcrowdfunding #fundraising #crowdfundingcampaign

Pumpinheart's miniaturised heart pump delivery and anchoring system fills a void! With over two million advanced stage diastolic Heart Failure patients in the USA, Canada, UK and EU in desperate need of a therapy, we want to share this short animated description of Pumpinheart's diastolic heart pump delivery and anchoring systems that are being developed to address this massive global unmet medical need. Kudos to Pumpinheart's biomedical engineering team led by Dr Darragh Colgan and Dr Andrew Malone and Pumpinheart's engineering consultant Gabriel Sobrino. #SparkCrowdfunding

Pumpinheart is delighted to announce the appointment of Charles Shambaugh (CS Engineering Design Services LLC, FL, USA) to Pumpinheart's biomedical engineering advisory team. With sixty one patents, and three issued personal patents, to his name Charles Shambaugh brings his extensive experience designing biomedical instrumentation and Class III medical devices and tools from concept through validation and transfer. As Director of Mechanical Systems Development R&D Early Development at HeartWare Inc (2004-2017) he conceived and designed multiple variants of the HeartWare Inc Miniature Axial-Flow Ventricular Assist Device (MVAD) and continues to innovate in the design and development of LVADs and ECMO medical devices to-date through his consultancy business. #HeartFailure #meddevice #medtechinnovator #SparkCrowdfunding

#TopCitedArticle Delighted to share that the Review article, titled 'Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy' published Open Access in the Journal of Anatomy by Wiley has been one of Journal's top 10 most-cited papers compared to the articles published 1st January 2022 – 31st December 2023 in the journal (citation data from Clarivate Analytics). Pumpinheart's CMO, Dr Aamir Hameed is the Senior Author on this paper and CSO, Dr Andrew Malone is a co-author. While the percutaneous LVADs are changing the landscape of heart failure management, it's imperative to learn from all the work that has been done already to mitigate the risks associated with a mechanical circulatory support (MCS) device like an LVAD and help bring the newer smarter MCS devices to market, to effectively manage heart failure patients and limit the complications. This paper describes the development of LVADs through landmark clinical trials in detail and describes the evolution of device design to reduce the risk of pump thrombosis and achieve better hemocompatibility. Whilst driveline infection, right heart failure and arrhythmias have been recognised as LVAD-related complications, this paper focuses on complications related to pump thrombosis, especially blood coagulopathy in detail and potential strategies to mitigate this complication. Furthermore, it also discusses the LVAD implantation techniques and their anatomical challenges. Here is the link to the paper: https://lnkd.in/eS8M7C4u Donald Hickey #heartfailure #LVAD #pumpthrombosis